NFA
JNP

Nationwide Fund Advisors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Nationwide Fund Advisors’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-56,000
Closed -$255K – 2935
2017
Q3 		$255K Hold
56,000
– – ﹤0.01% 2524
2017
Q2 		$283K Buy
56,000
+55,000
+5,500% +$246K ﹤0.01% 2476
2017
Q1 		$5K Hold
1,000
– – ﹤0.01% 3157
2016
Q4 		$6K Hold
1,000
– – ﹤0.01% 3152
2016
Q3 		$6K Buy
+1,000
New +$6.61K ﹤0.01% 3182

Other funds holding JNP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nationwide Fund Advisors's JNP Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2017, closing a stake of 56,000 shares — an estimated $255K sold.

Nationwide Fund Advisors first reported a position in JNP in Q3 2016 and held it in 5 quarters. The position peaked at $283K in Q2 2017. 36 funds tracked by Wall St. Rank hold JNP as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 56,000 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2017, an estimated $255K.
  • Nationwide Fund Advisors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2016 and held it in 5 quarters.
  • Nationwide Fund Advisors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $283K in Q2 2017.
  • 36 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.